BETA
BETA
Pieris Pharmaceuticals
PIRS82
$17.01arrow_drop_down1.73%-$0.30
High Quality
Penny Stock
PIRS82
$17.01
arrow_drop_down1.73%Performance History
| Key Stats | |
|---|---|
| Open | $7.52 |
| Prev. Close | $7.25 |
| EPS | -11.40 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $9.57M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 7.30 | 7.83 |
| 52 Week Range | 6.20 | 41.76 |
| Ratios | |
|---|---|
| Revenue | - |
| EPS | -11.40 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
Correlated Companies
About Pieris Pharmaceuticals (PIRS)
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Stephen S. Yoder J.D.
- Headquarters
- Boston
- Employees
- 127
- Exchange
- NASDAQ
Keep an eye on Pieris Pharmaceuticals
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Pieris Pharmaceuticals 's (PIRS) price per share?
The current price per share for Pieris Pharmaceuticals (PIRS) is $17.01. The stock has seen a price change of -$0.3 recently, indicating a -1.73% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Pieris Pharmaceuticals (PIRS)?
For Pieris Pharmaceuticals (PIRS), the 52-week high is $41.76, which is 145.5% from the current price. The 52-week low is $6.2, the current price is 174.35% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Pieris Pharmaceuticals (PIRS) a growth stock?
Pieris Pharmaceuticals (PIRS) has shown an average price growth of 0.41% over the past three years. It has received a score of 99 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Pieris Pharmaceuticals as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
What is Pieris Pharmaceuticals (PIRS) stock price performance year to date (YTD)?
As of the latest data, Pieris Pharmaceuticals (PIRS) has a year-to-date price change of 14.19%. Over the past month, the stock has experienced a price change of 95.29%. Over the last three months, the change has been 46.64%. Over the past six months, the figure is 32.97%. Looking at a longer horizon, the five-year price change stands at -95.17%.
help
Is Pieris Pharmaceuticals (PIRS) a profitable company?
Pieris Pharmaceuticals (PIRS) has a net income of -$24.54M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -10.01K% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 65.28%, providing insight into the company's sales performance and growth. The gross profit is $41.03M. Operating income is noted at -$15.84M. Furthermore, the EBITDA is -$3.86M.
help
What is the market capitalization of Pieris Pharmaceuticals (PIRS)?
Pieris Pharmaceuticals (PIRS) has a market capitalization of $22.46M. The average daily trading volume is 652.16K, indicating the stock's liquidity and investor engagement.
News
11/13/2023
Viridian Therapeutics, Inc. (VRDN) Reports Q3 Loss, Lags Revenue Estimates
NEWS
PENNY STOCKS
SMALL CAP
PRE-MARKET OUTLOOK
MARKETS
MOVERS
TRADING IDEAS
9/27/2023Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
9/25/2023
Pieris Pharmaceuticals (PIRS) Upgraded to Strong Buy: Here's Why
FEATURED
PENNY STOCKS WATCH LIST
BEST PENNY STOCKS
LIST OF PENNY STOCKS
PENNY STOCKS
PENNY STOCKS TO BUY
PENNY STOCKS TO WATCH
8/28/2023Best Penny Stocks To Buy Now? 10 Under $1 To Watch
NEWS
PENNY STOCKS
SMALL CAP
PRE-MARKET OUTLOOK
MARKETS
MOVERS
TRADING IDEAS
8/25/2023Why Affirm Holdings Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket
8/25/2023
Vanguard: Value stocks haven't been this cheap to growth since the COVID outbreak
Sign up for our newsletter
Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.